CN107114674A - 一种具有减肥功效的复合配方粉及其制备方法 - Google Patents
一种具有减肥功效的复合配方粉及其制备方法 Download PDFInfo
- Publication number
- CN107114674A CN107114674A CN201710397000.3A CN201710397000A CN107114674A CN 107114674 A CN107114674 A CN 107114674A CN 201710397000 A CN201710397000 A CN 201710397000A CN 107114674 A CN107114674 A CN 107114674A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- weight
- coconut
- oil microcapsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 144
- 230000000694 effects Effects 0.000 title claims abstract description 29
- 150000001875 compounds Chemical class 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 14
- 239000003094 microcapsule Substances 0.000 claims abstract description 53
- 239000002131 composite material Substances 0.000 claims abstract description 34
- 235000013162 Cocos nucifera Nutrition 0.000 claims abstract description 22
- 244000060011 Cocos nucifera Species 0.000 claims abstract description 22
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 22
- 239000008158 vegetable oil Substances 0.000 claims abstract description 22
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 18
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000003240 coconut oil Substances 0.000 claims abstract description 15
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 15
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 4
- 235000013339 cereals Nutrition 0.000 claims description 19
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 18
- 244000182216 Mimusops elengi Species 0.000 claims description 18
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 18
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 18
- 235000016709 nutrition Nutrition 0.000 claims description 16
- 230000035764 nutrition Effects 0.000 claims description 16
- 229940001941 soy protein Drugs 0.000 claims description 14
- 239000003623 enhancer Substances 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 6
- 235000015097 nutrients Nutrition 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims 3
- 239000000047 product Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 abstract description 11
- 230000037396 body weight Effects 0.000 abstract description 7
- 238000009776 industrial production Methods 0.000 abstract description 2
- 244000241838 Lycium barbarum Species 0.000 abstract 2
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 239000000428 dust Substances 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 210000000577 adipose tissue Anatomy 0.000 description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 102000016267 Leptin Human genes 0.000 description 5
- 108010092277 Leptin Proteins 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 235000003642 hunger Nutrition 0.000 description 5
- 229940039781 leptin Drugs 0.000 description 5
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000003813 safflower oil Substances 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 210000003016 hypothalamus Anatomy 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 229960004488 linolenic acid Drugs 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000021329 brown rice Nutrition 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 229940057917 medium chain triglycerides Drugs 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- -1 oryzanol Natural products 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010408 sweeping Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000037220 weight regain Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种具有减肥功效的复合配方粉及其制备方法，所述复合配方粉由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，按其重量份数计谷物粉10.5～50份、大豆分离蛋白9.0～40份、中链甘油三酯微囊粉7.5～35.5份、植物油微囊粉3.6～20.3份、椰子油微囊粉2.9～23份、椰子粉2.9～15份、枸杞粉0.1～10.5份、复合营养强化剂0.05～5份，通过混合方式获得；所述复合配方粉各组分协同作用，控制体重效果突出，适宜肥胖、超重和需要控制体重的人群食用，其制备方法简单，适合规模化工业生产的需要。
Description
技术领域
本发明涉及功能性食品领域，尤其是一种具有减肥功效的复合配方粉及其制备方法。
背景技术
2015年中国居民营养与慢性病状况报告显示，我国18岁及以上成年人超重率超过30％，肥胖率也超过10％，发病率逐渐增加，健康情况令人担忧。
目前控制体重的方法包括药物减肥、脱水减肥、高纤维食品等，都存在着呕吐、腹痛腹泻、虚弱、营养不良、体重回升等等副作用，缺少健康的体重管理营养品满足适宜于肥胖和需要控制体重的人群，并且可以减肥、减掉人体内部脂肪、增加瘦体重。
发明内容
本发明所要解决的技术问题在于提供一种具有减肥功效的复合配方粉。
本发明所要解决的另一技术问题在于提供上述具有减肥功效的复合配方粉的制备方法。
为解决上述技术问题，本发明的技术方案是：
一种具有减肥功效的复合配方粉，由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，按其重量份数计谷物粉10.5～50份、大豆分离蛋白9.0～40份、中链甘油三酯微囊粉7.5～35.5份、植物油微囊粉3.6～20.3份、椰子油微囊粉2.9～23份、椰子粉2.9～15份、枸杞粉0.1～10.5份、复合营养强化剂0.05～5份。
上述具有减肥功效的复合配方粉，根据生产需要添加食品添加剂0.05～5.5份。
优选的，上述具有减肥功效的复合配方粉，按其重量份数计谷物粉43份、大豆分离蛋白30份、中链甘油三酯微囊粉30份、植物油微囊粉13.5份、椰子油微囊粉15.5份、椰子粉10份、枸杞粉8.5份、复合营养强化剂2份。
上述具有减肥功效的复合配方粉的制备方法，具体步骤如下：
(1)按组方量称取谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂为原料，备用；
(2)混料：向枸杞粉中加入椰子粉、椰子油微囊粉、植物油微囊粉，混合5～15min；再将余下的原料加入混料罐，总混30～60min，即得。
上述具有减肥功效的复合配方粉的制备方法，添加食品添加剂时，先将食品添加剂与枸杞粉预混5～20min，再加入椰子粉、椰子油微囊粉、植物油微囊粉。
本发明的有益效果是：
上述具有减肥功效的复合配方粉，各组分协同作用，控制体重效果突出，适宜肥胖、超重和需要控制体重的人群食用，其制备方法简单，适合规模化工业生产的需要。
具体实施方式
实施例1
一种具有减肥功效的复合配方粉，由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，其中，谷物粉43kg、大豆分离蛋白30kg、中链甘油三酯微囊粉30kg、植物油微囊粉13.5kg、椰子油微囊粉15.5kg、椰子粉10kg、枸杞粉8.5kg、复合营养强化剂2kg。
上述具有减肥功效的复合配方粉的制备方法，具体步骤如下：
(1)按组方量称取谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂为原料，备用；
(2)混料：向枸杞粉中加入椰子粉、椰子油微囊粉、植物油微囊粉，混合10min；再将余下的原料加入混料罐，总混50min，即得。
实施例2
一种具有减肥功效的复合配方粉，由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，其中，谷物粉10.5kg、大豆分离蛋白40kg、中链甘油三酯微囊粉35.5kg、植物油微囊粉3.6kg、椰子油微囊粉2.9kg、椰子粉15kg、枸杞粉10.5kg、复合营养强化剂5kg。
制备方法同实施例1。
实施例3
一种具有减肥功效的复合配方粉，由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，其中，谷物粉50kg、大豆分离蛋白9.0kg、中链甘油三酯微囊粉7.5kg、植物油微囊粉20.3kg、椰子油微囊粉23kg、椰子粉2.9kg、枸杞粉0.1kg、复合营养强化剂0.05kg。
制备方法同实施例1。
实施例4
一种具有减肥功效的复合配方粉，由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，其中，谷物粉30kg、大豆分离蛋白20kg、中链甘油三酯微囊粉25.5kg、植物油微囊粉10.3kg、椰子油微囊粉17kg、椰子粉8kg、枸杞粉7.5kg、复合营养强化剂4kg。
制备方法同实施例1。
上述具有减肥功效的复合配方粉中各组分均为市售产品。其中，
谷物粉中含有丰富的营养物质，其主要成分荞麦中含有丰富的赖氨酸成分，铁、锰、锌等微量元素比一般谷物丰富，而且含有丰富膳食纤维。糙米保留着更多的镁、钾、钙、锌和铁等人体所必需的微量元素。糙米粉中含有丰富的抗活性氧植酸、阿魏酸等，可以抑制黑色素的产生，能促进新陈代谢，预防动脉硬化、内脏功能障碍和癌症等。
中链甘油三酯(MCT)供能低，同时可以促进矿物质、必须脂肪酸等营养物质的吸收，还可以减少体脂肪的积累、改善胰岛素敏感性。
椰子油对过氧化反应和腐臭有强大的抑制力，能帮助人体防止不饱和脂肪的过氧化反应，以及自由基造成的一切破坏。椰子油的饱和脂肪酸能增加人体有益胆固醇，从而降低疾病风险。
椰子粉，富含人体所需的十八种氨基酸、钙、锌、锰、铁、维生素C等营养元素，可均衡人体营养所需。
枸杞粉，有降低血糖、抗脂肪肝作用，并能抗动脉粥样硬化。
植物油微囊粉中含有大量红花籽油(含饱和脂肪酸6％，油酸21％，亚油酸73％)、亚麻籽油(α-亚麻酸含量为53％)以及数量可观的高级脂肪醇，甾醇和羟类等。由于其主要成分是亚油酸，能起到防止人体血清胆固醇在血管壁里沉积，防治动脉粥样硬化及心血管疾病的医疗保健效果，红花籽油中还含有大量的维生素E、谷维素、甾醇等药用成分，具有极好的保健作用；α-亚麻酸是人体必需脂肪酸，在人体内可转化为二十碳五烯酸和二十二碳六烯酸。α-亚麻酸有抗肿瘤，抗血栓，降血脂,营养脑细胞,调节植物神经等作用，亚麻籽油中还含有VE，是一种强有效的自由基清除剂，有延缓衰老和抗氧化的作用。
大豆分离蛋白能阻止尿钙损失，促进骨质健康，减少患骨质疏松的几率，且无消化不良、胃胀气等不适反应。
且研究表明，维生素缺少会导致肥胖。维生素B1有助于体内葡萄糖被利用转换成热量，加速肝糖的消耗利用。维生素B2则可帮助脂肪燃烧，它是脂肪转化为能量、体力不可或缺的营养素。摄入后燃烧了脂肪，避免脂肪贮积于体内，还有扫除肠道的作用。维生素B6是体内许多重要酶系统的辅酶，它参与蛋白质、不饱和脂肪酸等营养素的代谢。维生素D通过调节体内钙代谢和抑制甲状腺激素，避免细胞钙流失，抑制肥胖发生。
综上，各组分协同作用，从多方面对食用者进行调节：
提高基础代谢率，益于体重的管理，使脂肪被迅速燃烧、分解，转化为能量，使食用者无饥饿感，且有效提高人体的能量代谢，促进脂肪分解，减少体脂积累；
长期食用有益于瘦素等水平调整，当人体能量摄入正平衡时，体脂增加，促使脂肪细胞瘦素分泌增多，瘦素作用于下丘脑，结合其受体，产生饱食反应，从而降低食欲，减少能量摄取，促进能量消耗；当人体体重降低时，脂肪组织瘦素分泌下降，作用于下丘脑的另一受体，产生饥饿反应，增加食欲，提高摄食量，降低能耗。
驯化并建立新的体脂调节点，慢慢的改善激素水平，人体调节体重和脂肪水平的过程与调节血糖、血压一样，都是一个复杂的信号系统，这个信号能控制你的食欲、消化、能量平衡和代谢，以保持你的体重和脂肪处于一种稳定水平，我们称之为体脂(体重)调节点。如果发生了长期变化，那么体重改变之后，不会回归原始设定点，而是会适应长期变化，形成一个新的设定点；即通过营养治疗调整与训化体脂调节点，长期服用可以降低定点，建立新的体制调节点。
实验例1
以安慰剂(单谷物粉)作对照，随机交叉双盲实验，50名健康受试者(30-40岁，身高与体重比按kg/cm计为3-4:8)随机分为对照组和实验组两组，实验组服用实施例1所述复合配方粉，1周的研究时间，食用者服用量相同，监测食用者的耐饥饿程度，发现实验组的全部受试者在食用实施例1所述复合配方粉6个小时后均无任何饥饿感，而对照组受试者则多半以上出现饥饿感。
实验例2
以安慰剂作对照随机交叉双盲实验(同实验例1)，在随后为期8周的体重维持随访期间，试验组受试者(服用实施例1所述复合配方粉)身体体重显著降低6.3±7.8㎏(p<0.05)，BMI值显著降低2.2±1.7kg/m2(p<0.05)，腰围显著降低3.9±5.8cm(p<0.05)，对照组受试者无明显变化。
上述参照实施例对该一种具有减肥功效的复合配方粉及其制备方法进行的详细描述，是说明性的而不是限定性的，可按照所限定范围列举出若干个实施例，因此在不脱离本发明总体构思下的变化和修改，应属本发明的保护范围之内。
Claims (3)
1.一种具有减肥功效的复合配方粉，其特征在于：由谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂，按其重量份数计谷物粉10.5～50份、大豆分离蛋白9.0～40份、中链甘油三酯微囊粉7.5～35.5份、植物油微囊粉3.6～20.3份、椰子油微囊粉2.9～23份、椰子粉2.9～15份、枸杞粉0.1～10.5份、复合营养强化剂0.05～5份。
2.根据权利要求1所述的具有减肥功效的复合配方粉，其特征在于：按其重量份数计谷物粉43份、大豆分离蛋白30份、中链甘油三酯微囊粉30份、植物油微囊粉13.5份、椰子油微囊粉15.5份、椰子粉10份、枸杞粉8.5份、复合营养强化剂2份。
3.权利要求1所述具有减肥功效的复合配方粉的制备方法，其特征在于：具体步骤如下：
(1)按组方量称取谷物粉、大豆分离蛋白、中链甘油三酯微囊粉、植物油微囊粉、椰子油微囊粉、椰子粉、枸杞粉、复合营养强化剂为原料，备用；
(2)混料：向枸杞粉中加入椰子粉、椰子油微囊粉、植物油微囊粉，混合5～15min；再将余下的原料加入混料罐，总混30～60min，即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710397000.3A CN107114674A (zh) | 2017-05-31 | 2017-05-31 | 一种具有减肥功效的复合配方粉及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710397000.3A CN107114674A (zh) | 2017-05-31 | 2017-05-31 | 一种具有减肥功效的复合配方粉及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107114674A true CN107114674A (zh) | 2017-09-01 |
Family
ID=59730228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710397000.3A Pending CN107114674A (zh) | 2017-05-31 | 2017-05-31 | 一种具有减肥功效的复合配方粉及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107114674A (zh) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108576830A (zh) * | 2018-05-14 | 2018-09-28 | 中科天润特益（天津）生物科技有限公司 | 一种具有多种保健功能的营养保健品及其制备方法 |
| CN109007840A (zh) * | 2018-09-18 | 2018-12-18 | 广东雪芝康生物科技有限公司 | 一种通过调节基因减肥降血脂的植物营养粉及其制备方法 |
| CN110140966A (zh) * | 2019-05-15 | 2019-08-20 | 诸暨市众创机械设备厂 | 一种茶籽油风味减肥保健代餐食品及其制备方法 |
| CN116530683A (zh) * | 2023-07-04 | 2023-08-04 | 北京衡美金叶营养健康科技有限公司 | 增强脂肪代谢用的食品组合物及其制备方法 |
| CN117770452A (zh) * | 2023-03-21 | 2024-03-29 | 中恩（天津）医药科技有限公司 | 一种具有减重降脂功效的膳食食品 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228069A (zh) * | 2011-06-21 | 2011-11-02 | 北京康比特体育科技股份有限公司 | 一种用于减肥代餐的烘焙棒及其制备方法 |
| CN105747235A (zh) * | 2016-03-04 | 2016-07-13 | 通泰心脑健康管理有限公司 | 一种能改善代谢综合征症状的饮食组合物 |
| CN106072517A (zh) * | 2016-06-08 | 2016-11-09 | 青岛尚医制药有限公司 | 一种减肥食品及其制备工艺 |
-
2017
- 2017-05-31 CN CN201710397000.3A patent/CN107114674A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102228069A (zh) * | 2011-06-21 | 2011-11-02 | 北京康比特体育科技股份有限公司 | 一种用于减肥代餐的烘焙棒及其制备方法 |
| CN105747235A (zh) * | 2016-03-04 | 2016-07-13 | 通泰心脑健康管理有限公司 | 一种能改善代谢综合征症状的饮食组合物 |
| CN106072517A (zh) * | 2016-06-08 | 2016-11-09 | 青岛尚医制药有限公司 | 一种减肥食品及其制备工艺 |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108576830A (zh) * | 2018-05-14 | 2018-09-28 | 中科天润特益（天津）生物科技有限公司 | 一种具有多种保健功能的营养保健品及其制备方法 |
| CN109007840A (zh) * | 2018-09-18 | 2018-12-18 | 广东雪芝康生物科技有限公司 | 一种通过调节基因减肥降血脂的植物营养粉及其制备方法 |
| CN110140966A (zh) * | 2019-05-15 | 2019-08-20 | 诸暨市众创机械设备厂 | 一种茶籽油风味减肥保健代餐食品及其制备方法 |
| CN117770452A (zh) * | 2023-03-21 | 2024-03-29 | 中恩（天津）医药科技有限公司 | 一种具有减重降脂功效的膳食食品 |
| CN117770452B (zh) * | 2023-03-21 | 2024-08-13 | 中恩（天津）医药科技有限公司 | 一种具有减重降脂功效的膳食食品 |
| CN116530683A (zh) * | 2023-07-04 | 2023-08-04 | 北京衡美金叶营养健康科技有限公司 | 增强脂肪代谢用的食品组合物及其制备方法 |
| CN116530683B (zh) * | 2023-07-04 | 2023-10-20 | 北京衡美金叶营养健康科技有限公司 | 增强脂肪代谢用的食品组合物及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107114674A (zh) | 一种具有减肥功效的复合配方粉及其制备方法 | |
| CN102742837B (zh) | 一种用于改善营养不良症状的保健食品及其制备方法 | |
| CN101690507B (zh) | 一种添加低聚糖的粗粮保健月饼及制作方法 | |
| CN102366093A (zh) | 一种复合减肥保健食品 | |
| CN105533505B (zh) | 一种咀嚼型鱼油复合软胶囊及其制备方法 | |
| CN106858618A (zh) | 一种减肥大豆蛋白组合物及其制备方法与应用 | |
| CN111802635A (zh) | 一种减肥/控重型可吸果冻及其制备方法 | |
| KR20200062654A (ko) | 유산균 발효물을 함유하는 숙취해소용 조성물 | |
| CN107981351B (zh) | 一种调节体脂肪率的膳食性微胶囊颗粒及其制备方法 | |
| CN109602019A (zh) | 一种具有降低体脂含量功能的益生菌食品及其制备方法 | |
| CN110692884A (zh) | 一种辅助降四高的益生菌保健饮料 | |
| CN102178077A (zh) | 一种产鹅肥肝朗德鹅的饲料添加剂 | |
| CN101095520A (zh) | 一种具有降脂减肥作用的功能食品 | |
| KR101515253B1 (ko) | 아디포넥틴 분비 촉진 및/또는 감소 억제제 | |
| CN103190677A (zh) | 一种谷物固体饮料及其制备工艺 | |
| CN106974263A (zh) | 一种能降脂减肥，复合益生菌植物酵素粉的制备方法 | |
| KR101521341B1 (ko) | 북두근, 북두근 추출물, 북두근 오니 또는 북두근 맥아 효소액 추출물을 유효성분으로 함유하는 식욕부진 예방 또는 치료용 조성물 | |
| CN115969045A (zh) | 一种具有体重健康管理功能的组合物及其制备方法与应用 | |
| CN113678990A (zh) | 一种灵芝养生燕麦片及其制作方法 | |
| KR20130108044A (ko) | 프로바이오틱스 쿠키바 제조방법 및 조성물 | |
| CN106923335A (zh) | 一种运动营养的功能组合物及应用 | |
| CN109364202B (zh) | 一种组合物及其制备方法和应用 | |
| CN105076816B (zh) | 一种宠物狗零食南瓜条及其制备方法 | |
| CN110537671A (zh) | 一种乳酸菌发酵红小豆制备复合营养粉及其生产工艺 | |
| CN102871003B (zh) | 一种肉猪用营养汤料及制作方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170901 |